Luigi Porcaro
Overview
Explore the profile of Luigi Porcaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ardissino G, Cresseri D, Mancuso M, Capone V, Porcaro L, Amico V, et al.
J Nephrol
. 2024 Jan;
37(4):1017-1026.
PMID: 38280096
Background: Atypical-hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy often due to uncontrolled complement activation, characterized by high risk of end-stage kidney disease (ESKD). Eculizumab has improved the outcome,...
2.
Topa M, Porcaro L, Basilisco G
Gastroenterology
. 2023 Jun;
165(6):1338-1341.
PMID: 37286093
No abstract available.
3.
Cugno M, Mancini I, Consonni D, De Zan V, Ardissino G, Griffini S, et al.
Blood
. 2023 Mar;
141(18):2278-2282.
PMID: 36877895
No abstract available.
4.
Colombo C, Ramm G, Lindblad A, Corti F, Porcaro L, Alghisi F, et al.
J Cyst Fibros
. 2023 Feb;
22(2):263-265.
PMID: 36739240
Cystic-fibrosis-related liver disease (CFLD) is a variable phenotype of CF. The severe CFLD variant with cirrhosis or portal hypertension has a poor prognosis and life expectancy. CFTR modulator therapies are...
5.
Pariano M, Puccetti M, Stincardini C, Napolioni V, Gatticchi L, Galarini R, et al.
Am J Respir Cell Mol Biol
. 2022 Oct;
68(3):288-301.
PMID: 36252182
Hypoxia contributes to the exaggerated yet ineffective airway inflammation that fails to oppose infections in cystic fibrosis (CF). However, the potential for impairment of essential immune functions by HIF-1α (hypoxia-inducible...
6.
Ardissino G, Capone V, Tedeschi S, Porcaro L, Cugno M
Pharmaceuticals (Basel)
. 2022 Jul;
15(7).
PMID: 35890144
Thrombotic microangiopathy (TMA) is a complication that may occur after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) and is conventionally called transplant-associated thrombotic microangiopathy (TA-TMA). Despite the many efforts...
7.
Reschini M, Benaglia L, Ceriotti F, Borroni R, Ferrari S, Castiglioni M, et al.
Sci Rep
. 2022 May;
12(1):8467.
PMID: 35589752
There is growing interest on the potential clinical relevance of the endometrial microbiome. However, insufficient attention has been given to the methodology of sampling. To minimize contamination, we advocate the...
8.
Cugno M, Capone V, Griffini S, Grovetti E, Pintarelli G, Porcaro L, et al.
J Nephrol
. 2022 Jan;
35(4):1205-1211.
PMID: 35013983
Background: Atypical hemolytic uremic syndrome (aHUS) is characterized by platelet consumption, hemolysis, and renal injury. Eculizumab, a humanized antibody that blocks complement activity, has been successfully used in aHUS, but...
9.
Rodrigues E, Ardissino G, Pintarelli G, Capone V, Mariotti J, Verna M, et al.
Thromb Haemost
. 2021 Dec;
122(7):1247-1250.
PMID: 34965590
No abstract available.
10.
Ardissino G, Longhi S, Porcaro L, Pintarelli G, Strumbo B, Capone V, et al.
Kidney Int Rep
. 2021 Jun;
6(6):1614-1621.
PMID: 34169201
Introduction: Atypical hemolytic uremic syndrome (aHUS) is mainly due to complement regulatory gene abnormalities with a dominant pattern but incomplete penetrance. Thus, healthy carriers can be identified in any family...